P M Campbell

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. doi request reprint Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation
    Patricia Campbell
    Department of Medicine and Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada
    Curr Opin Organ Transplant 18:463-9. 2013
  2. ncbi request reprint Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation
    P M Campbell
    Department of Medicine, Division of Nephrology and Immunology, University of Alberta, Capital Health, Edmonton, Alberta, Canada
    Am J Transplant 7:1242-8. 2007
  3. doi request reprint De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure
    L G Hidalgo
    Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 9:2532-41. 2009
  4. doi request reprint NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection
    L G Hidalgo
    Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada
    Am J Transplant 10:1812-22. 2010
  5. ncbi request reprint High risk of sensitization after failed islet transplantation
    P M Campbell
    Department of Medicine, and Histocompatability Laboratory, University of Alberta, Capital Health, Edmonton, Alberta, Canada
    Am J Transplant 7:2311-7. 2007
  6. doi request reprint Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure
    G Einecke
    Alberta Transplant Applied Genomics Centre, Department of Medicine, Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 9:2520-31. 2009
  7. ncbi request reprint Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause
    B Sis
    Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 7:1743-52. 2007
  8. pmc Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?
    S Urschel
    Department of Pediatrics, Cardiac Transplant Research, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 10:149-56. 2010
  9. ncbi request reprint Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
    K Solez
    University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:518-26. 2007

Detail Information

Publications9

  1. doi request reprint Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation
    Patricia Campbell
    Department of Medicine and Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada
    Curr Opin Organ Transplant 18:463-9. 2013
    ..Whether to accept or decline an organ if the virtual crossmatch is positive, when to monitor and whether to treat de-novo donor-specific antibody (DSA) posttransplant remain challenging issues for the transplant clinician...
  2. ncbi request reprint Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation
    P M Campbell
    Department of Medicine, Division of Nephrology and Immunology, University of Alberta, Capital Health, Edmonton, Alberta, Canada
    Am J Transplant 7:1242-8. 2007
    ....
  3. doi request reprint De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure
    L G Hidalgo
    Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 9:2532-41. 2009
    ..We propose careful assessment of de novo DSA, particularly against class II, be performed in all late kidney transplant biopsies...
  4. doi request reprint NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection
    L G Hidalgo
    Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada
    Am J Transplant 10:1812-22. 2010
    ..Thus, the strategy of using DSASTs in the biopsy to identify mechanism-related transcripts in biopsies from patients with clinical phenotypes indicates the selective involvement of NK cells in ABMR...
  5. ncbi request reprint High risk of sensitization after failed islet transplantation
    P M Campbell
    Department of Medicine, and Histocompatability Laboratory, University of Alberta, Capital Health, Edmonton, Alberta, Canada
    Am J Transplant 7:2311-7. 2007
    ..This may negatively impact the ability of these individuals to undergo further islet, pancreas or kidney transplantation and should be discussed upfront during evaluation of candidates for islet transplantation...
  6. doi request reprint Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure
    G Einecke
    Alberta Transplant Applied Genomics Centre, Department of Medicine, Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 9:2520-31. 2009
    ..The major cause of late kidney transplant failure is antibody-mediated microcirculation injury, but detection of this phenotype requires new diagnostic criteria...
  7. ncbi request reprint Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause
    B Sis
    Laboratory Medicine and Pathology, and Medicine, Division of Nephrology and Transplantation Immunology, University of Alberta, Edmonton, AB, Canada
    Am J Transplant 7:1743-52. 2007
    ..The remaining 27%, mostly BD, may be a different disease or a stage in which A and C are undetectable...
  8. pmc Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?
    S Urschel
    Department of Pediatrics, Cardiac Transplant Research, University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 10:149-56. 2010
    ..This difference was present also when comparing only children transplanted below 2 years of age. Therefore, tolerance toward the donor blood group appears to be associated with an altered response to HLA beyond age-related effects...
  9. ncbi request reprint Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
    K Solez
    University of Alberta, Edmonton, Alberta, Canada
    Am J Transplant 7:518-26. 2007
    ..Participation of B cells in allograft rejection and genomics markers of rejection were also major subjects addressed by the conference...